Business Context and Reporting Period
Company: BIOHARVEST SCIENCES INC.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Filing Date: August 11, 2026
Reporting Period: This filing serves as a cover document submitting Unaudited Interim Condensed Consolidated Financial Statements and Management's Discussion and Analysis (MD&A) for the three and six months ended June 30, 2026. The registrant files annual reports under Form 40-F.
Key Financial Metrics
The provided text is a cover sheet and does not contain the actual financial data. The specific values for revenue, profit, cash flow, margins, debt, and liquidity are located in the attached exhibits (Exhibit 99.1 and 99.2) which are not included in the input text. Therefore, the filing text does not provide a clear value for any financial metric.
Material Changes
No material changes versus the prior comparable period can be identified from the provided text, as the comparative financial data is absent.
Guidance, Outlook, and Risks
The input text does not contain management commentary, guidance, outlook, risks, contingencies, or unusual items. These details are expected to be found in Exhibit 99.2 (Management's Discussion and Analysis).
Investor Verification Checklist
- Review Exhibit 99.1 for the actual Unaudited Interim Condensed Consolidated Financial Statements to verify revenue, net income, and cash position for the period ended June 30, 2026.
- Examine Exhibit 99.2 for Management's Discussion and Analysis to understand operational performance, liquidity risks, and future outlook.
- Confirm the company's status as a Foreign Private Issuer filing under Form 40-F rather than Form 20-F.
- Verify the certifications provided by the CEO and CFO in Exhibits 99.3 and 99.4 regarding the accuracy of the interim filings.